Optometrist

NovaSight Announces Publication of CureSight(TM)’s Pivotal Study of One-Year Follow-Up Outcomes

Study Demonstrates That Patients Achieved Long-Term Visual Acuity Gains Following CureSight TreatmentAIRPORT CITY, ISRAEL / ACCESSWIRE / March 13, 2024…

1 week ago

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis

Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution…

2 weeks ago

Grand Opening of Coastal Vision Medical Group’s Advanced Office in Orange, CA

State-of-the-Art Eye Care Facility Opens to Serve Orange County CommunityORANGE, CA / ACCESSWIRE / February 15, 2024 / Coastal Vision…

1 month ago

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today the completion of its…

3 months ago

Dr. Parul Khator Becomes First Doctor In Georgia to Use the iTrack Advance Canaloplasty Device for Glaucoma

Minimally invasive device reduces intraocular pressure for adults with open angle glaucomaATLANTA--(BUSINESS WIRE)--Georgia Eye Partners is proud to share that…

7 months ago

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY…

7 months ago

NovaSight Announces Publication of CureSight(TM)’s Pivotal Study of One-Year Follow-Up Outcomes

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis

Grand Opening of Coastal Vision Medical Group’s Advanced Office in Orange, CA

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States

Dr. Parul Khator Becomes First Doctor In Georgia to Use the iTrack Advance Canaloplasty Device for Glaucoma

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

Association for Pediatric Vision Announces a Free Vision Screening Training Offered Nationwide

Virginia’s Largest Ophthalmology, Optometry Clinic, and Storefront Transitions to eClinicalWorks Vision Solutions

RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy

Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million